The table below shows aTYR PHARMA INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$190.00K
$235.00K
$353.00K
$10.39M
$0.00
$10.46M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$60.22M
$54.37M
$42.29M
$42.81M
$23.26M
$17.29M
SG&A
LIFE annual revenue (10-K history)
aTYR PHARMA INC reported annual revenue of $190.00K for fiscal year 2025. That is down 19.1% from $235.00K in fiscal 2024. Over the 7 fiscal years shown, annual revenue declined from $422.00K (FY 2019) to $190.00K. Figures come from the company's audited annual reports as filed with the SEC.
